Skip to content
healthcare.dev

Glipizide

NDC 43353-207, Glipizide, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
43353-207
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074223
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43353-207 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
43353-207-454335302074545 TABLET in 1 BOTTLE, PLASTIC (43353-207-45)
43353-207-604335302076090 TABLET in 1 BOTTLE, PLASTIC (43353-207-60)
43353-207-8043353020780180 TABLET in 1 BOTTLE, PLASTIC (43353-207-80)
43353-207-9443353020794360 TABLET in 1 BOTTLE, PLASTIC (43353-207-94)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d6c016f7-bf93-4322-a179-d4798234b381

Use it

Look up 43353-207 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43353-207 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43353-207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.